Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Enovis Community
NYSE:ENOV Community
1
Narratives
written by author
0
Comments
on narratives written by author
4
Fair Values set
on narratives written by author
Create a narrative
Enovis
Popular
Undervalued
Overvalued
Community Investing Ideas
Enovis
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
New Product Pipeline Will Unlock International Orthopedic Markets
Key Takeaways Successful product innovation and past acquisitions position Enovis for international market expansion and consistent revenue and earnings growth. Shifting sourcing away from China is expected to reduce costs and improve net margins amid stable pricing and operational efficiencies.
View narrative
US$58.00
FV
45.6% undervalued
intrinsic discount
5.96%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
10 days ago
author updated this narrative
Your Valuation for
ENOV
ENOV
Enovis
Your Fair Value
US$
Current Price
US$31.56
66.0% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-812m
4b
2015
2018
2021
2024
2025
2027
2030
Revenue US$2.9b
Earnings US$411.0m
Advanced
Set Fair Value